Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients

Journal of Cataract and Refractive Surgery - Tập 30 - Trang 1653-1660 - 2004
Kerry D Solomon1, Eric D Donnenfeld2, Michael Raizman3, Helga P Sandoval1, Katherine Stern4, Amanda VanDenburgh4, Janet K Cheetham4, Rhett Schiffman4
1From Storm Eye Institute, Medical University of South Carolina, Department of Ophthalmology, Charleston, SC, USA
2Ophthalmic Consultants of Long Island, Long Island, NY, USA
3New England Eye Center, Tufts University School of Medicine, Boston, MA, USA
4Allergan, Inc., Irvine, CA, USA

Tài liệu tham khảo

Solomon, 2001, Comparison of ketorolac tromethamine 0.5 and rimexolone 1 to control inflammation after cataract extraction; prospective randomized double-masked study., J Cataract Refract Surg, 27, 1232, 10.1016/S0886-3350(00)00832-4

Guidera, 2001, Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs., Ophthalmology, 108, 936, 10.1016/S0161-6420(00)00538-8

Heier, 1999, Ketorolac tromethamine 0.5 ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial., Am J Ophthalmol, 127, 253, 10.1016/S0002-9394(98)00413-9

Holzer, 2002, Comparison of ketorolac tromethamine 0.5 and loteprednol etabonate 0.5 for inflammation after phacoemulsification; prospective randomized double-masked study., J Cataract Refract Surg, 28, 93, 10.1016/S0886-3350(01)01185-3